Biocon Ltd held its 47th Annual General Meeting on August 08, 2025, where the Chairperson emphasized the company's focus on accessible medicines and reported a 5% revenue growth to ₹164,699 million and a profit of ₹10,133 million for FY25, highlighting a strong performance in their Biosimilars business with a 15% growth.